Why the study?
What are the rates, risk factors, and costs associated with 30-day readmission after surgery for advanced-stage ovarian cancer in a Medicare population?
Population
5,152 patients with stage IIIC/IV ovarian, primary peritoneal, or fallopian tube cancer from the…
Design
Cohort
Follow-up
30 days for readmission, 1 year for mortality
Authors
Loading...
30-day readmission after ovarian cancer surgery marks higher mortality risk; leaves open whether targeted prevention improves survival in Medicare patients.
What are the rates, risk factors, and costs associated with 30-day readmission after surgery for advanced-stage ovarian cancer in a Medicare population?
Early readmission after surgery for advanced ovarian cancer is common (19.5%) and is associated with significantly increased 1-year mortality.
Eskander et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: